MiniMed Group, Inc. (MMED) Fair Value 2026

MMED · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.3 /10

32 fundamental signals · 2 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-27, MiniMed Group, Inc. (MMED) trades at $19.51, versus a $19.51 median fair value across its 2 active models — 0.0% below the current price. QOC: 6.3/10. Value Trap Risk: 13/100 (SAFE). 2/13 models active.

Key Facts

Ticker
MMED
Price
$19.51
Quality Score
6.3/10
Value Trap Risk
13/100
Models Active
2/13
Last Updated
Strength: FTNN Topology suggests +29.2% upside with 7% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is MiniMed Group, Inc. (MMED) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, MiniMed Group, Inc. (MMED) appears fairly valued as of : the median of 2 independent fair value estimates is $19.51, essentially in line with the current price of $19.51. Estimates range from $13.80 to $25.22. MMED scores 6.3/10 on fundamental quality and 13/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. MMED’s -0.0% gap is narrower than that market norm, and the Medical Instruments & Supplies sector median is -36.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy MiniMed Group, Inc. Stock in 2026? →

What Fair Value Does Each Model Give MMED?

2 Intrinsic Value Models vs. Current Price ($19.51)

Core Models (Unlocked)
Model Fair Value Upside
Relative · Medium Conviction
 $13.80 -29.2%
Relative · Low Conviction
 $25.22 +29.2%

All Models Active

All 2 models are displayed above.

What Is MiniMed Group, Inc. (MMED) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, MiniMed Group, Inc.'s intrinsic value is estimated at a median $19.51, showing conflicting signals at the current price of $19.51. While the median implied return is -0.0%, model disagreement is elevated with a gap of +58.5% between the most bullish and bearish estimates. The most optimistic model, FTNN, places fair value at $25.22 (+29.2%), while Regime Cross — the most conservative — estimates $13.80 (-29.2%). This +58.5% gap reflects genuine analytical uncertainty about MiniMed Group, Inc.'s intrinsic worth.

What Do the Models Say About MMED?

2 of 13 models are currently active for MMED. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for MMED is $19.51 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does MMED Rank in Medical Instruments & Supplies?

Among 55 Medical Instruments & Supplies stocks, MMED ranks #31 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.

See all Most Undervalued Medical Instruments & Supplies Stocks →

MiniMed Group, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MMED a Value Trap?

CirclFi's Value Trap algorithm assigns MMED a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for MiniMed Group, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, MiniMed Group, Inc.'s fundamental quality profile registers 6.3/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +58.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MMED valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MMED's 2 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy MiniMed Group, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

BAXBaxter International Inc.QOC 6.3BLCOBausch + Lomb CorporationQOC 6.3KRMDKORU Medical Systems, Inc.QOC 6.5TFXTeleflex IncorporatedQOC 6.2AVTRAvantor, Inc.QOC 6.5RVPRetractable Technologies, Inc.QOC 6.2LUCYLucyd, IncQOC 5.6LMATLeMaitre Vascular, Inc.QOC 9.3STVNStevanato Group S.p.A.QOC 7.7ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: BAX · BLCO · KRMD · TFX · AVTR · RVP · LUCY · LMAT · STVN · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to MMED?

7 companies across all industries closest to MMED’s Quality of Company score of 6.3/10.

SNOASonoma Pharmaceuticals, Inc.QOC 6.3INDIindie Semiconductor, Inc.QOC 6.3RLYBRallybio CorporationQOC 6.3BWMGBrownie's Marine Group, Inc.QOC 6.3SEPNSepterna, Inc.QOC 6.3CARLCarlsmed, Inc.QOC 6.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SNOA · INDI · RLYB · BWMG · SEPN · CARL · NVDA

Where Does MMED Sit in CirclFi's Medical Instruments & Supplies Rankings?

MMED is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About MiniMed Group, Inc.’s Valuation?

What is MiniMed Group, Inc.'s intrinsic value in 2026?

CirclFi puts MiniMed Group, Inc. (MMED)'s intrinsic value at $19.51 — the median of 2 independent model estimates as of 2026-08-27, ranging from $13.80 to $25.22. The Quality of Company score is 6.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MMED overvalued or undervalued right now?

At $19.51, 1 of 2 active models suggest MMED may be undervalued, while 1 indicate potential overvaluation. The median of all 2 fair value estimates is $19.51, essentially in line with the current price of $19.51 — a consensus view that MMED is fairly valued. The assessment depends on which methodology best fits MiniMed Group, Inc.'s business model in Medical Instruments & Supplies.

What does a Quality of Company score of 6.3 mean for MMED?

MiniMed Group, Inc.'s QOC of 6.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on MMED?

CirclFi analyzes MMED with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is MMED a value trap in 2026?

MiniMed Group, Inc.'s Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, MiniMed Group, Inc. (MMED) has a median fair value of $19.51 — essentially in line with the current price of $19.51 — as of 2026-08-27.” Source: circlfi.com/stock/MMED/ · Methodology
Primary sources for this MMED valuation
  • Financial statements: MiniMed Group, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0002062583) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MMED as of ; valuations recomputed .